Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and D

Recombinant adenovirus serotype 5 (rAd5) vector-based vaccines are currently being developed for both human immunodeficiency virus type 1 and other pathogens. The potential limitations associated with rAd5 vectors, however, have led to the construction of novel rAd vectors derived from rare Ad serot...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Abbink, Peter, Lemckert, Angelique A. C., Ewald, Bonnie A., Lynch, Diana M., Denholtz, Matthew, Smits, Shirley, Holterman, Lennart, Damen, Irma, Vogels, Ronald, Thorner, Anna R., O'Brien, Kara L., Carville, Angela, Mansfield, Keith G., Goudsmit, Jaap, Havenga, Menzo J. E., Barouch, Dan H.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2007
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1900173/
https://ncbi.nlm.nih.gov/pubmed/17329340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02696-06
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados